iShares Bitcoin Trust vs Medtronic PLC — how do they compare? iShares Bitcoin Trust trades at $37.77, while Medtronic PLC trades at $82.95 (market cap $106.61B). The key difference: Medtronic PLC pays a 3.46% dividend while iShares Bitcoin Trust pays none, and Medtronic PLC is trading nearer its 52-week high, iShares Bitcoin Trust nearer its low. Which is the better fit depends on your goals.
| IBIT | MDT | |
|---|---|---|
Sector | Crypto-linked | Health |
52-Week High | $71.29 | $105.35 |
52-Week Low | $33.29 | $73.75 |
Market Cap | — | $106.61B |
Enterprise Value | — | $125.36B |
Dividend Yield | — | 3.46% |
Signals from Pluang's Aura AI — not financial advice
IBIT trades at $36.89, up 1.49% with neutral technical signals. The stock shows mixed momentum with bearish moving averages but neutral oscillators. Recent news highlights IBIT's position as a leading Bitcoin ETF with $44.9 billion in assets under management, surpassing Fidelity's competing fund. The ETF faces headwinds from significant outflows in June 2026 but maintains institutional interest as a preferred Bitcoin exposure vehicle.
Outlook remains cautious amid Bitcoin market volatility and ETF outflow pressures. Investment opportunity lies in IBIT's dominant market position and institutional adoption, balanced against cryptocurrency market risks and competitive ETF landscape. Key risks include Bitcoin price sensitivity and regulatory uncertainty affecting fund flows.
Medtronic (MDT) trades at $83.54, up 0.41% today, with a bullish technical signal from moving averages. The company reported strong revenue growth to $33.54B in 2025 and has beaten EPS estimates for three consecutive quarters. Recent acquisitions, including SPR and Scientia Vascular, expand its pain therapy and neurovascular portfolios. Valuation ratios show a P/E of 22.31 and P/S of 2.95, with a consensus price target of $97.50 implying significant upside.
The outlook is positive, supported by robust fundamentals, analyst optimism, and strategic expansions. Key risks include rising debt levels and competitive pressures in medical technology. With no sell ratings from analysts and a dividend yield near a decade high, MDT presents a compelling long-term opportunity for growth and income investors, though macroeconomic and execution risks warrant monitoring.
Trailing returns across standard periods
Latest headlines on both assets
IBIT is a spot Bitcoin ETF that tracks the price of Bitcoin directly. Managed by BlackRock, it offers investors a regulated way to gain exposure to the digital asset within a traditional brokerage account.
Read more on IBIT →One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →